Methylprednisolone vs Risankizumab

## Methylprednisolone vs Risankizumab: Overview

This comparison examines the pharmacological differences between **Methylprednisolone** and **Risankizumab**.

## Mechanism of Action

**Methylprednisolone**: Intermediate-acting synthetic glucocorticoid.

## Pharmacokinetics

**Half-life**: Methylprednisolone — 18-36 hours; Risankizumab — N/A.

## Chemical Properties

**Molecular Formula**: Methylprednisolone — C22H30O5; Risankizumab — N/A.

**Molecular Weight**: Methylprednisolone — 374.4710 g/mol; Risankizumab — N/A.

**Type**: Methylprednisolone — Small molecule; Risankizumab — Antibody.